Progressive trichomegaly.
Vano-Galvan
S
S
Dermatology Service, Ramon y Cajal Hospital, University of Alcala, Madrid, Spain. sergiovano@yahoo.es
Moreno-Martin
P
P
Jaén
P
P
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001763:Blepharoptosis / Q000139:chemically induced* / Q000209:etiology; D000068818:Cetuximab; D018450:Disease Progression; D005140:Eyelashes / Q000002:abnormalities* / Q000187:drug effects; D005260:Female; D006801:Humans; D006983:Hypertrichosis / Q000139:chemically induced*; D008875:Middle Aged; D012307:Risk Factors
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab